One possible explanation ... and one for sure price mover ..After brainstorming for awhile, I came up with one scenario that might explain why they are so "closed mouths" on an "open trial". Suppose the data is soooooo good that they don't want to wake up big pharma yet. They may want to get well down the Phase 1 schedule before having to deal with BP nagging at then and their patents.
I also know of one way to get the share price to rocket ... all I would have to do is sell all my shares. Not ready to make that sacrifice for you all yet ;)
-LT